Mark Yarchoan

Assistant Professor

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mark Yarchoan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Neoplasms Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Proto-Oncogene Proteins B-raf Medicine & Life Sciences
Tumor Burden Medicine & Life Sciences
Thyroid Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

Leaf, R. K., Ferreri, C., Rangachari, D., Mier, J., Witteles, W., Ansstas, G., Anagnostou, T., Zubiri, L., Piotrowska, Z., Oo, T. H., Iberri, D., Yarchoan, M., Salama, A. K. S., Johnson, D. B., Leavitt, A. D., Rahma, O. E., Reynolds, K. L. & Leaf, D. E., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Autoimmune Hemolytic Anemia
Coombs Test
Preexisting Condition Coverage

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Chan, T. A., Yarchoan, M., Jaffee, E., Swanton, C., Quezada, S. A., Stenzinger, A. & Peters, S., Jan 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 1, p. 44-56 13 p.

Research output: Contribution to journalArticle

Tumor Burden

Immune-related adverse events requiring hospitalization: Spectrum of toxicity, treatment, and outcomes

Balaji, A., Zhang, J., Wills, B., Marrone, K., Elmariah, H., Yarchoan, M., Zimmerman, J. W., Hajjir, K., Venkatraman, D., Armstrong, D. K., Laheru, D., Mehra, R., Ho, W. J., Reuss, J. E., Heng, J., Vellanki, P., Donehower, R. C., Holdhoff, M. & Naidoo, J., Jan 1 2019, In : Journal of oncology practice. 15, 9, p. E825-E834

Research output: Contribution to journalArticle

Referral and Consultation

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

Jafarnejad, M., Sové, R. J., Danilova, L. V., Mirando, A. C., Zhang, Y., Yarchoan, M., Tran, P. T., Pandey, N., Fertig, E. & Popel, A. S., Dec 1 2019, In : npj Systems Biology and Applications. 5, 1, 29.

Research output: Contribution to journalArticle

Open Access
Systems Biology
Hepatocyte Growth Factor
Growth Factors

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

Yarchoan, M., Mohan, A. A., Dennison, L., Vithayathil, T., Ruggieri, A., Lesinski, G. B., Armstrong, T. D., Azad, N. S. & Jaffee, E. M., Oct 2019, In : PloS one. 14, 10, e0224600.

Research output: Contribution to journalArticle

Open Access
Regulatory B-Lymphocytes
Mitogen-Activated Protein Kinase Kinases